Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial - Discussion

被引:0
|
作者
Keye, WR
机构
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:1487 / 1488
页数:2
相关论文
共 50 条
  • [1] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
    Miller, JD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) : 1483 - 1487
  • [2] Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial
    Franke, HR
    van de Weijer, PHM
    Pennings, TMM
    van der Mooren, MJ
    FERTILITY AND STERILITY, 2000, 74 (03) : 534 - 539
  • [3] Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study
    Osuga, Yutaka
    Seki, Yoshifumi
    Tanimoto, Masataka
    Kusumoto, Takeru
    Kudou, Kentarou
    Terakawa, Naoki
    FERTILITY AND STERILITY, 2021, 115 (02) : 397 - 405
  • [4] ELAGOLIX, AN ORAL GONADOTROPIN-RELEASING HORMONE ANTAGONIST, FOR THE MANAGEMENT OF ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY AND EFFICACY RESULTS FROM TWO DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES.
    Taylor, H. S.
    Giudice, L. C.
    Lesley, B. A.
    Abrao, M.
    Kotarski, J.
    Williams, L. A.
    Rowan, J. P.
    Chwalisz, K.
    Duan, W. R.
    Schwefel, B.
    Thomas, J. W.
    Jain, R. I.
    FERTILITY AND STERILITY, 2016, 106 (03) : E271 - E271
  • [5] Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial
    Carr, BR
    Breslau, NA
    Peng, N
    Adams-Huet, B
    Bradshaw, KD
    Steinkampf, MP
    FERTILITY AND STERILITY, 2003, 80 (05) : 1216 - 1223
  • [6] Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: A multicenter, randomized, double-blind study
    Vercellini, P
    Soma, M
    Moro, GL
    Jasonni, V
    Naldi, S
    Benedetto, G
    Mais, V
    Bruni, V
    Rosati, D
    Venturini, PL
    Semino, A
    Crosignani, PG
    Aimi, G
    Vignali, M
    Colombo, P
    Paoletti, R
    FERTILITY AND STERILITY, 1996, 66 (06) : 911 - 919
  • [7] LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Donnez, J.
    Taylor, H.
    Gemzell-Danielsson, K.
    Catherino, W.
    Bestel, E.
    Gotteland, J. P.
    Humberstone, A.
    Moore, L.
    Garner, E.
    HUMAN REPRODUCTION, 2022, 37 : I111 - I111
  • [8] Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain
    Kitawaki, Jo
    Kusuki, Izumi
    Yamanaka, Kaoruko
    Suganuma, Izumi
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 157 (02) : 212 - 216
  • [9] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Diamond, Michael P.
    Carr, Bruce
    Dmowski, W. Paul
    Koltun, William
    O'Brien, Chris
    Jiang, Ping
    Burke, Joshua
    Jimenez, Roland
    Garner, Elizabeth
    Chwalisz, Kristof
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 363 - 371
  • [10] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Michael P. Diamond
    Bruce Carr
    W. Paul Dmowski
    William Koltun
    Chris O’Brien
    Ping Jiang
    Joshua Burke
    Roland Jimenez
    Elizabeth Garner
    Kristof Chwalisz
    Reproductive Sciences, 2014, 21 : 363 - 371